Recent progress of chemotherapy and biomarkers for gastroesophageal cancer

Key cytotoxic drugs of chemotherapy for gastroesophageal cancer include fluoropyrimidine, platinum, taxanes and irinotecan. Concurrent chemoradiotherapy is one of the main treatment strategies, especially for esophageal cancer. As molecular target agents, the anti-HER2 antibody trastuzumab for HER2-...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Osamu, Ando, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657220/
https://www.ncbi.nlm.nih.gov/pubmed/31367271
http://dx.doi.org/10.4251/wjgo.v11.i7.518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657220/
https://www.ncbi.nlm.nih.gov/pubmed/31367271
http://dx.doi.org/10.4251/wjgo.v11.i7.518

Ejemplares similares